We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Pfizer has teamed up with Arvinas to co-develop and co-commercialise ARV-471, the latter’s investigational oral PROTAC oestrogen receptor protein degrader. ARV-471 is currently in a Phase 2 study
Swiss drugmaker Novartis was ruled by the California District Court to pay $178m in damages to Plexxikon for infringing cancer drugs patent rights. Plexxikon, a company of the
Pfizer and BioNTech have teamed up with South Africa-based biopharmaceutical firm Biovac to manufacture and distribute their Covid-19 vaccine in the African Union. Under the partnership, Biovac will
AstraZeneca has closed its previously announced acquisition of Alexion Pharmaceuticals to create a new unit ‘Alexion, AstraZeneca Rare Disease’, based in Boston, US. The British drugmaker has paid
Octapharma USA has obtained the US Food and Drug Administration (FDA) approval for Octagam 10% [Immune Globulin Intravenous] to treat adult dermatomyositis. Dermatomyositis is a rare idiopathic autoimmune
Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve (casirivimab and imdevimab), developed by Roche and Regeneron, to treat patients with mild to moderate Covid-19. Ronapreve
Sanofi has received the US Food and Drug Administration (FDA) approval for fexinidazole to treat a type of sleeping sickness, also called Human African trypanosomiasis. The US regulator
The US state attorneys general are anticipated to unveil a $26bn settlement this week to resolve claims that the three drug distributors and drugmaker Johnson & Johnson (J&J)
Merck has received the US Food and Drug Administration (FDA) approval for Vaxneuvance, its pneumococcal 15-valent conjugate vaccine, for active immunisation in adults. The vaccine is indicated for
GSK has unveiled its plans to build a large hub for biotechnology and other early-stage life science companies at its existing 92-acre research and development site in Stevenage,